Northwest Naturals is recalling nearly 2,000 pounds of raw cat and dog food after federal testing found salmonella and Listeria monocytogenes contamination in two chicken products distributed nationwide.

The Portland, Oregon-based company is voluntarily recalling 53 cases, or 1,272 pounds, of Northwest Naturals Frozen Chicken Recipe and 19 cases, or 684 pounds, of Northwest Naturals Frozen Raw Diet for Dogs Chicken Recipe, according to a company announcement posted Friday by the Food and Drug Administration.

The recall covers a total of 1,956 pounds of product.

The 2-pound Frozen Chicken Recipe, which is marketed as cat food and a protein topper for dogs, tested positive for salmonella. The 6-pound Frozen Raw Diet for Dogs Chicken Recipe tested positive for both salmonella and Listeria monocytogenes, according to the announcement.

NEARLY 25K POUNDS OF FROZEN BUFFALO CHICKEN RECALLED OVER INSPECTION LAPSE

The recall covers a total of 1,956 pounds of product. (Getty Images)

The contamination was identified after product samples were collected and tested by the FDA. No illnesses had been reported in connection with the recall as of Aug. 28, the company said.

The affected 2-pound Frozen Chicken Recipe bears lot number B-5, a best-by date of Jan. 26, 2028, and UPC 087316384956. The affected 6-pound Frozen Raw Diet for Dogs Chicken Recipe bears lot number B-19, a best-by date of Jan. 25, 2028, and UPC 087316380392. The recalled products were distributed to retail stores nationwide.

Northwest Naturals Chicken Recipe raw frozen pet food is among the products recalled over possible salmonella contamination. (Northwest Naturals / FDA)

Salmonella and Listeria monocytogenes can sicken animals that eat contaminated products and can also pose a risk to people who handle the food or come into contact with contaminated surfaces, according to the recall notice.

Pets infected with either bacteria may experience lethargy, diarrhea or bloody diarrhea, fever, vomiting, decreased appetite, and abdominal pain. Infected animals can also carry the bacteria and potentially spread them to people or other animals.

Northwest Naturals Raw Diet for Dogs Chicken Recipe is being recalled after testing found salmonella and Listeria monocytogenes. (Northwest Naturals/FDA)

Consumers who purchased the affected products are being advised to stop feeding them to their pets and return the unused portion to the place of purchase for a full refund.

CLICK HERE TO GET FOX BUSINESS ON THE GO

Northwest Naturals also advised consumers handling raw pet food to wash their hands thoroughly and clean and sanitize bowls, utensils, surfaces and storage areas that come into contact with the products.

FOX Business reached out to Northwest Naturals for additional comment.

Securities and Exchange Board of India (SEBI) chairman Tuhin Kanta Pandey on August 27 said the market regulator was close to clearing the draft red herring prospectus (DRHP) filed by NSE, the world’s largest derivatives exchange by trading volume.

NSE filed its draft prospectus in June for an IPO that will comprise entirely of an offer for sale (OFS), allowing existing shareholders to pare their stakes. The exchange had initially expected SEBI clearance for its DRHP by early August. The timeline was subsequently pushed back by around three weeks following changes to the roster of selling shareholders, with SBI Capital Markets being added.

At the top end of the marketed valuation of Rs 5.26 lakh crore ($55 billion), NSE would rank sixth among global exchange operators by market capitalisation, narrowly behind London Stock Exchange Group Plc and ahead of Nasdaq Inc, according to Bloomberg.

NSE unlisted share price

Live Events

NSE’s unlisted shares are currently changing hands at around Rs 1,970, according to data from Unlisted Arena. The shares were quoted at around Rs 2,010 when NSE filed its DRHP.
Over the past year, the unlisted stock has traded in a range of around Rs 1,800-2,150, well below its June 2025 peak of Rs 2,590.The shares had slipped to around Rs 1,950 on July 28-29 before recovering to current levels.

ALSO READ: NSE IPO coming soon: Should investors buy unlisted shares now or wait for the mega issue?

With NSE’s IPO expected in the second half of September, investors are now assessing whether to enter the stock through the unlisted market or wait for the public offering and its eventual listing.

How to buy NSE unlisted shares

NSE shares currently trade in the unlisted, over-the-counter market, where investors can acquire equity in companies ahead of their listing on recognised stock exchanges.

Unlike a listed stock, NSE’s unlisted shares do not have a continuous exchange-based price discovery mechanism or a live market price. Trades are negotiated privately between buyers and sellers, with the final transaction price depending on the prevailing quote and available liquidity.

Investors looking to acquire NSE shares can approach SEBI-registered investment banks, brokers or specialised unlisted-share dealers. These intermediaries facilitate transactions by matching investors seeking to buy pre-IPO shares with existing shareholders looking to sell.

Investors can also purchase shares directly from existing shareholders, including promoters, founders, angel investors and employees holding vested ESOPs. Such transactions are generally negotiated over the counter and may involve sizeable minimum ticket sizes.

Pre-IPO platforms also aggregate such opportunities and facilitate the KYC, price discovery and share-transfer process.

Step-by-step process to buy NSE unlisted shares

Choose an intermediary or platform: Register with a specialised unlisted-share platform or dealer offering NSE shares.

Complete KYC: Submit documents including PAN, Aadhaar, bank account details and the Client Master Report (CMR/CML) issued by your depository participant. The CMR contains details such as your demat account, DP ID, Client ID and linked bank account.

Check the quote and lot size: Unlike an exchange-traded stock, there is no central order book or exchange-determined price for NSE’s unlisted shares. Buyers and sellers negotiate the transaction price and quantity, with intermediaries facilitating the trade.

Place the order and make payment: Once the price and quantity are agreed upon, the buyer transfers funds through the payment channel specified by the platform, including UPI, NEFT, RTGS or a designated escrow account.

Complete the transfer documentation: Depending on the transaction, documentation may include the share purchase agreement (SPA), delivery instruction slip (DIS), proof of payment and transfer deed (SH-4).

Receive the shares in the demat account: Once the transaction is verified and the seller confirms the transfer, the shares are moved through an off-market transfer and credited to the buyer’s demat account through the depository system. The shares may typically be credited within 24 to 48 business hours, according to the details provided.

The two depositories, CDSL and NSDL, oversee the electronic transfer of shares. Proper documentation is critical to establishing the transfer of title, as unlisted transactions do not pass through the standard order-matching and settlement mechanism of a stock exchange.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Lawrence Fuller is the Principal of Fuller Asset Management (FAM), a state registered investment adviser. He is also the manager of the Focused Growth portfolio on the copy-trading platform Dubapp.com. Information presented is for educational purposes only intended for a broad audience. The information does not intend to make an offer or solicitation for the sale of purchase of any specific securities, investments, or investment strategies. Investments involve risk and are not guaranteed. FAM has reasonable belief that this marketing does not include any false or material misleading statements or omissions of facts regarding services, investment, or client experience. FAM has reasonable belief that the content as a whole will not cause an untrue or misleading implication regarding the adviser’s services, investments, or client experiences. Past performance of specific investment advice should not be relied upon without knowledge of certain circumstances or market events, nature and timing of investments and relevant constraints of the investment. FAM has presented information in a fair and balanced manner. FAM is not giving tax, legal, or accounting advice.
Mr. Fuller may discuss and display charts, graphs, formulas, and stock picks which are not intended to be used by themselves to determine which securities to buy or sell, or when to buy or sell them. Such charts and graphs offer limited information and should not be used on their own to make investment decisions. Consultation with a licensed financial professional is strongly suggested. The opinions expressed herein are those of the firm and are subject to change without notice. The opinions referenced are as of the date of publication and are subject to change due to changes in market or economic conditions and may not necessarily come to pass.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Budget airline easyJet is expected to return to the FTSE 100 in this week’s index reshuffle after its shares were boosted by a recommended £5.7 billion takeover offer from the American private equity firm Apollo Capital Management.

As things stand, the airline would be joined in the top flight by Ithaca Energy, the North Sea oil and gas producer, while the gambling group Entain and the housebuilder Persimmon face relegation to the FTSE 250. Aston Martin Lagonda, the lossmaking carmaker, is set to fall out of the FTSE 250 altogether and drop into the FTSE SmallCap index.

The changes are not yet official. Index provider FTSE Russell’s indicative review is based on market data from 21 August, and the review proper will be conducted using prices at the close of trading on 1 September. The confirmed changes will be announced after the market closes on 2 September.

Under FTSE Russell’s ground rules for its UK index series, most recently updated in July, a company is removed from the FTSE 100 at the quarterly review if it has fallen to 111th place or below when companies are ranked by full market capitalisation.

Takeover bid powers easyJet’s return

For easyJet, promotion would mark a return to an index it has been in and out of over the years, and it comes despite issues with price-sensitive customers over the summer and heavy losses last winter.

Quite how long the airline stays in the premier index is another matter. That will depend on how long the regulatory investigation into the Apollo deal takes, and on whether Brussels is prepared to wave through the new ownership structure.

Ithaca Energy’s market value has climbed to about £4.5 billion, helped by strong financial results and higher oil and gas prices. The British oil and gas company’s shares have risen about 64 per cent this year, with investors also attracted by its growth pipeline.

Gambling tax rise and budget nerves take their toll

At the other end of the table, Entain has fallen about 30 per cent this year. The owner of Ladbrokes and Coral has been hit by the rise in UK remote gaming duty from 21 per cent to 40 per cent, which applies to accounting periods beginning on or after 1 April this year.

Persimmon is also expected to leave the FTSE 100 after its shares fell about 13 per cent this year. The housebuilder is contending with weak housing activity, concerns over mortgage affordability, uncertainty in the run up to the October budget and higher costs, including national insurance and stamp duty.

Aston Martin heads the other way

Aston Martin’s relegation from the FTSE 250 is the latest setback for the carmaker, which announced plans to cut about 600 jobs, around a fifth of its workforce, earlier this year after net losses widened by 52 per cent to £493.2 million.

Two companies are on course to take places in the mid-cap index in its wake. Pinewood Technologies Group, the automotive technology company that is itself the subject of a takeover offer, and Volex, Lord Rothschild’s electrical manufacturing company, are both set for promotion to the FTSE 250.

Amy Ingham

Amy Ingham is a reporter at Business Matters, covering UK business news with a focus on breaking news, business policy, late payments and insolvency. She joined the magazine in 2026 after completing the NCTJ Diploma in Journalism at Harlow College’s journalism school. Her recent reporting includes British Steel’s nationalisation and its impact on SME suppliers, the decline in late payments by large firms, and Insolvency Service director disqualifications. Reach her at aingham@cbmeg.co.uk.

This article was written by

Follow

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ALVO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

“We will watch out if this leads to an exit among senior leaders of the bank. This can impact business and performance in the near term,” analysts at the firm said.

The brokerage said its conversations with investors suggest they are comfortable with a leadership change, but believe the appointment of former leaders from PSU banks should be avoided as it could complicate the transition.

Also read: HDFC Bank shares after Jagdishan: What lies ahead for the country’s largest private lender?

Who can become new HDFC Bank CEO?

Jefferies sees Kaizad Bharucha, HDFC Bank’s Deputy Managing Director who leads corporate, business banking and retail assets, among others, as a key internal candidate for the CEO role.

Live Events

The brokerage said Bharucha could be a simpler choice, with a potential tenure of 2.8-3 years, given that he was appointed Executive Director in June 2014. It believes one option for the bank could be to allow Bharucha to lead HDFC Bank while preparing for a smoother transition over the longer term.
Jefferies identified Anup Bagchi, currently CEO of ICICI Prudential Life and formerly an Executive Director at ICICI Bank overseeing retail banking; Paresh Sukthankar, former DMD at HDFC Bank who left in 2018; Vibha Padalkar, CEO of HDFC Life; Rajiv Sabharwal, CEO of Tata Capital; and Amitabh Chaudhry, CEO of Axis Bank, as potential external candidates.

Jefferies on HDFC Bank outlook

The brokerage has lowered its FY27-29 earnings estimates by 3% each. It does not see a risk to asset quality, noting that the bank has maintained high asset quality and that the book value of its exposure to the Essel group was nil at the time of the merger, with the claim including principal and interest.

Analysts say the uncertainty could raise the cost of equity and lead to a lower valuation, prompting it to base the revised target on 1.6x September 2028 adjusted price-to-book value. However, with HDFC Bank trading at 1.5x one-year forward price-to-book and 12x PE, the brokerage believes valuations are not as demanding.

The bank said in an exchange filing over the weekend that its board had tried to persuade Jagdishan to continue, but he remained firm on his decision not to seek re-appointment. HDFC Bank’s board has now decided to accelerate the process of identifying his successor, well within the timeframe stipulated by the regulator.

Read more: HDFC Bank shares gain 3% as CEO Jagdishan rejects new term; Morgan Stanley, Jefferies, others weigh in

Among the names being considered internally is current Deputy Managing Director Kaizad Bharucha, who has been with HDFC Bank’s board since 2014 and became Deputy MD in April 2023. However, the 15-year cap set by the Reserve Bank of India on the tenure of a Whole-Time Director at a private bank presents a limitation. Bharucha’s current term on the board runs until 2029.

HDFC Bank stock performance

The stock has remained under pressure this year. HDFC Bank shares have fallen 27.33% on a year-to-date basis and are down 24.80% over the past one year, according to NSE data. Over five years, the stock has declined nearly 6.97%.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times.)